ARIA (Allergic rhinitis and its impact on asthma) Achievements in 10 years and future needs

Yorgancioglu A., ÖZDEMİR C., Kalayci O., Kalyoncu A. F. , Bachert C., Baena-Cagnani C. E. , ...More

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.60, no.1, pp.92-97, 2012 (ESCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 60 Issue: 1
  • Publication Date: 2012
  • Doi Number: 10.5578/tt.3734
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.92-97
  • Hacettepe University Affiliated: Yes


Allergic rhinitis and asthma represent global health problems for all age groups. Asthma and rhinitis frequently co-exist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization (WHO) workshop in 1999 and was published in 2001. ARIA has reclassified allergic rhinitis as mild/moderate-severe and intermittent/persistent. This classification schema closely reflects the impact of allergic rhinitis on patients. In its 2010 Revision, ARIA developed clinical practice guidelines for the management of allergic rhinitis and asthma co-morbidities based on GRADE (Grading of Recommendation, Assessment, Development and Evaluation). ARIA has been disseminated and implemented in over 50 countries of the world. In Turkey, it is important to make a record of ARIA achievements and to identify the still unmet clinical, research and implementation needs in order to strengthen the 2011 EU Priority on allergy and asthma in children.